1. Home
  2. MLP vs DCTH Comparison

MLP vs DCTH Comparison

Compare MLP & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLP

Maui Land & Pineapple Company Inc.

N/A

Current Price

$15.91

Market Cap

323.5M

Sector

Finance

ML Signal

N/A

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.91

Market Cap

311.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLP
DCTH
Founded
1909
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
323.5M
311.7M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
MLP
DCTH
Price
$15.91
$10.91
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$22.00
AVG Volume (30 Days)
16.5K
272.1K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.53
EPS
N/A
0.07
Revenue
$19,457,000.00
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
N/A
$33.15
P/E Ratio
N/A
$155.43
Revenue Growth
68.24
N/A
52 Week Low
$13.84
$8.12
52 Week High
$20.34
$18.23

Technical Indicators

Market Signals
Indicator
MLP
DCTH
Relative Strength Index (RSI) 50.69 73.40
Support Level $15.75 $10.50
Resistance Level $16.48 $11.25
Average True Range (ATR) 0.38 0.32
MACD 0.08 0.18
Stochastic Oscillator 57.84 92.58

Price Performance

Historical Comparison
MLP
DCTH

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating parent company that owns land and commercial property on the island of Maui, Hawaii. The Company puts its assets into productive use by planning, managing, developing, and selling residential, resort, commercial, agricultural, and industrial real estate. Its segments include land development and sales, which cover land planning, entitlement, development, construction, and sales of land assets; leasing, which generates revenue from real property leasing, license fees and royalties, and includes maintenance of real estate assets, conservation activities, and management of water systems in West and Upcountry Maui; and resort amenities, which include a membership program offering benefits within the Kapalua Resort.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: